Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 28, 2017
Pharmacy Choice - Pharmaceutical News - Data on Periodontitis Described by Researchers at Seoul National University Bundang Hospital (Randomized controlled clinical trial of 2 types of... - April 28, 2017

Pharmacy News Article

 3/20/17 - Data on Periodontitis Described by Researchers at Seoul National University Bundang Hospital (Randomized controlled clinical trial of 2 types of...

Data on Periodontitis Described by Researchers at Seoul National University Bundang Hospital (Randomized controlled clinical trial of 2 types of hydroxyapatite-coated implants on moderate periodontitis patients)

By a News Reporter-Staff News Editor at Clinical Trials Week Investigators publish new report on Periodontal Diseases and Conditions - Periodontitis. According to news reporting out of Seongnam, South Korea, by NewsRx editors, research stated, "The aim of this study was to compare and analyze the peri-implant tissue conditions and prospective clinical outcomes associated with 2 types of hydroxyapatite (HA)-coated implants: (1) fully HA-coated implants and (2) partially HA-coated implants with resorbable blast medium on the coronal portion of the threads. Forty-four partially edentulous patients were randomly assigned to undergo the placement of 62 HA-coated implants, and were classified as the control group (partially HA-coated, n=30) and the test group (fully HA-coated, n=32)."

Our news journalists obtained a quote from the research from Seoul National University Bundang Hospital, "All patients had chronic periodontitis with moderate crestal bone loss around the edentulous area. The stability and clinical outcomes of the implants were evaluated using the primary and secondary implant stability quotient (ISQ), as well as radiographic, mobility, and peri-implant soft tissue assessments around the implants. The Wilcoxon signed-rank test and the Mann-Whitney test were used to evaluate differences between and within the 2 groups, with values <0.05 considered to indicate statistical significance. The fully HA-coated implants displayed good retention of crestal bone, and insignificant differences were found in annual marginal bone loss between the 2 types of HA-coated implants (>0.05). No significant differences were found in the survival rate (group I, 100%; group II, 100%) or the success rate (group I, 93.3%; group II, 93.8%). The fully HA-coated implants also did not significantly increase the risk of peri-implantitis (>0.05). The fully HA-coated implants did not lead to an increased risk of peri-implantitis and showed good retention of the crestal bone, as well as good survival and success rates."

According to the news editors, the research concluded: "Our study suggests that fully HA-coated implants could become a reliable treatment alternative for edentulous posterior sites and are capable of providing good retention of the crestal bone."

For more information on this research see: Randomized controlled clinical trial of 2 types of hydroxyapatite-coated implants on moderate periodontitis patients. Journal of Periodontal & Implant Science, 2016;46(5):337-349 (see also Periodontal Diseases and Conditions - Periodontitis).

Our news journalists report that additional information may be obtained by contacting H.S. Kim, Dept. of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, South Korea. Additional authors for this research include P.Y. Yun and Y.K Kim.

Keywords for this news article include: Asia, Seongnam, Phosphates, South Korea, Bone Research, Periodontitis, Hydroxyapatites, Phosphoric Acids, Clinical Research, Clinical Trials and Studies, Mouth Diseases and Conditions, Periodontal Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Apr 30: Using Effective Communication to Reduce Medication Errors
May 01: The New Hypertension Guidelines: What are They Telling Us?
May 02: Treatment of Depression and Anxiety in Older Adults
May 03: The Common Cold: An Update for Pharmacy Professionals
May 04: Treatment of Parkinson's Disease and Comorbid Conditions
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415